5:40 PM
 | 
Sep 24, 2009
 |  BC Extra  |  Politics & Policy

FDA to reevaluate Menaflex approval process

FDA released a report on Thursday recommending a reevaluation of the approval of a 510(k) application from ReGen Biologics Inc. (OTCBB:RGBO) for Menaflex collagen meniscus implant for reinforcement and repair of soft tissue injuries of...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >